Transition From Research to Disclosure in Human Genetics
1 other identifier
observational
577
1 country
1
Brief Summary
The goal of this study is to design a means of providing research families, from diverse geographical locations, the chance to receive genetic testing after having been educated by video, and meetings or telephone conversations with a genetic counselor/study professional. This is an investigational study. About 800 people will be offered genetic testing. This study is being performed only at MD Anderson.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 1999
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 6, 1999
CompletedFirst Submitted
Initial submission to the registry
July 19, 2007
CompletedFirst Posted
Study publicly available on registry
July 23, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 8, 2022
CompletedMarch 4, 2022
March 1, 2022
22.8 years
July 19, 2007
March 3, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants Received Pre-test Genetic Counseling
10 Years
Secondary Outcomes (1)
Number of participants completing genetic testing for p53
Baseline to time of follow-up (2 weeks, 6, and 12 months)
Study Arms (1)
Pre-Test Genetic Counseling + Genetic Sample
Interventions
Genetic counseling conducted in person, by telephone with an M. D. Anderson Genetic Counselor, or with a local Genetic Counselor in conference with the M. D. Anderson Genetic Counselor.
Eligibility Criteria
Patient diagnosed with cancer or a participant with a family member who has had cancer.
You may qualify if:
- Genetic testing
- Members of families who have participated in the p53 project through Dr. Strong's lab are eligible, via protocol P90-001. There are at least 145 kindreds including at least 800 participants living who may be at risk of carrying a p53 germline mutation. The participants must provide an informed consent and be 18 years or older. We will include English and non-English speaking participants. For non-English speaking participants to be recruited, the consent documents has been translated into the language of the target population in accordance with the IRB procedures.
- Parents Attitudes toward testing children at risk for TP53 mutations
- For the survey portion of this study, we will invite individuals who 1) are already enrolled in the P90-001 study), 2) have been known to carry a germline p53 mutation, and 3) have children who are less than 27 years old. Patients who agree to enroll in the survey portion of the study will be presented with a consent statement and a printed copy of the survey along with a postage-paid envelope which they can return (either by mail or in person) at their convenience.
- Psychosocial impact of participating in LFS screening
- Adults who have undergone genetic testing and have a confirmed p53 mutation
- Adults participating in LFS screening program
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
Biospecimen
Optional small sample of blood (about 6 tablespoons) for genetic testing for p53 following pre-test genetic counseling.
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Louise C. Strong, MD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2007
First Posted
July 23, 2007
Study Start
May 6, 1999
Primary Completion
February 8, 2022
Study Completion
February 8, 2022
Last Updated
March 4, 2022
Record last verified: 2022-03